Topic: Lipid Nanoparticles

FOIA-requested data reveals that lipid nanoparticles do not stay at the injection site but instead accumulate in high concentrations in the ovaries and other organs. There is a significant concern regarding the reverse transcription of mRNA into DNA via the Line 1 retrotransposon, which is critical for embryogenesis. The promotion of these products to pregnant women is criticized as criminal due to the total lack of long-term safety data for fetuses and lactating mothers.

Dr. Richard Amerling describes the biological process of mRNA vaccines, expressing concern over the body's production of pathogenic spike proteins. He suggests that those who did not produce the protein after injection are the "lucky ones" and recommends antibody testing to verify immune status. Amerling warns of potential long-term consequences, including autoimmune diseases, fertility issues, and interference with immune surveillance mechanisms that prevent cancer.